Page 3 - Viral Vector News Today

Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The

Allied Market Research published a report, titled, “Gene Therapy Market by Vector Type (Viral Vector, Non-Viral Vector), by Therapy (In Vivo Therapy, Ex Vivo Therapy), by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors, Others), by Application (Oncological Disorders, Ra...

Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The

Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The

Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The

NEWARK, Del., Oct. 10, 2023 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) officially launches the Viral Vectors NIIMBL-led Program focused on developing and making broadly available

Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The

A new UK based gene therapy company has entered the sector starting with the launch of an inhaled delivery treatment for rare respiratory disorders.

TrakCel is a provider of integrated cellular orchestration solutions for the management, control and tracking of cell and gene therapy products.

TrakCel is a provider of integrated cellular orchestration solutions for the management, control and tracking of cell and gene therapy products.